Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary
Read More
weight
Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access
Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new
Read More
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t
Read More
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
For investors all-in on Magnificent 7-led market, ‘equal weight’ is trending as stock call
Investors are facing a period of historically high concentration in the S&P 500 Index headed into 2026, with a small
Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in
Read More
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on
Read More
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing
A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials,
Read More